賽力斯(601127.SH):新能源車產品SERES 5已在歐洲銷售;已在歐洲、亞洲、美洲、非洲等地建立超過1000家營銷服務網點
格隆匯7月17日丨有投資者向賽力斯(601127.SH)提問,“各大新能源車紛紛開拓海外市場,請問貴公司在海外投資和市場佔比如何?”
賽力斯回覆稱,目前,公司新能源車產品SERES 5已經在歐洲銷售,首批用户交付儀式於6月21日在挪威卑爾根弗洛伊恩山舉行。公司已在歐洲、亞洲、美洲、非洲等地建立超過1000家營銷服務網點,累計出口70多個國家和地區。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.